Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Teens’ Social Media Use Does Not Predict Later Depression
THURSDAY, Feb. 28, 2019 (HealthDay News) — Social media use does not predict later depressive symptoms among adolescents or college undergraduates, according to a study recently published in Clinical Psychological Science.
Mental Health Disorders Up After Head & Neck Cancer Diagnosis
THURSDAY, Feb. 28, 2019 (HealthDay News) — In patients with head and neck cancer (HNC), the prevalence of mental health disorders (MHDs) is significantly higher after cancer diagnosis, according to a study published online Feb. 28 in JAMA Otolaryngology-Head & Neck Surgery.
Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — Maternal prenatal vitamin intake during the first month of pregnancy is associated with a reduced risk for autism spectrum disorder (ASD) in siblings of children with ASD, according to a study published online Feb. 27 in JAMA Psychiatry.
Green Space in Childhood Tied to Better Mental Health Later
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — Living around high levels of green space during childhood is associated with a lower risk for a wide spectrum of psychiatric disorders later in life, according to a study published online Feb. 25 in the Proceedings of the National Academy of Sciences.
Contributors to Delay of Multiple Sclerosis Diagnosis ID’d
TUESDAY, Feb. 26, 2019 (HealthDay News) — First symptoms and disease type are contributors to delays in multiple sclerosis (MS) diagnosis, according to a study recently published in the Multiple Sclerosis Journal.
Atypical Temporal Work Patterns Linked to Depressive Symptoms
TUESDAY, Feb. 26, 2019 (HealthDay News) — Women working extra-long hours and men and women working weekends have increased depressive symptoms, according to a study published online Feb. 25 in the Journal of Epidemiology & Community Health.
Sertraline Tops CBT for Reducing Depression in Dialysis Patients
TUESDAY, Feb. 26, 2019 (HealthDay News) — For patients receiving maintenance hemodialysis, an engagement interview on treatment acceptance has no effect on acceptance of depression treatment, and depression scores are modestly better with sertraline treatment versus cognitive behavioral therapy (CBT) after 12 weeks of treatment, according to a study published online Feb. 26 in the Annals of Internal Medicine.